Headaches, or cephalgia, are common neurological conditions that can substantially disrupt daily functioning. They encompass various types, including migraine, tension-type headache, cluster headache, and other common forms. Globally, headaches affect approximately 40% of the population, with migraines accounting for nearly half of the total burden (
1,
2). Tension-type headache is the most prevalent primary headache disorder, affecting approximately 20% of individuals and having a lifetime prevalence of 46% to 78% (
3,
4). It is associated with substantial psychosocial and economic consequences (
3,
4). Between 1990 and 2019, its prevalence increased in the Middle East and North Africa, where the burden exceeded global levels across all demographics despite unchanged incidence. Cluster headache, although the most common trigeminal autonomic cephalalgia, remains uncommon, affecting approximately 0.1% of the general population (
5,
6). Given their high global prevalence, headaches remain an important focus of clinical care and public health research.
Tension-type headache, also called “muscle contraction,” “stress,” or “psychomyogenic” headache, often involves muscle tenderness that worsens with increasing headache frequency and severity (
7). It is classified as episodic (frequent or infrequent) or chronic according to episode frequency. Its precise cause remains unclear, but genetic, environmental, nutritional, and muscular factors have been implicated (
3,
7). Tension-type headache causes substantial disability and leads to more missed workdays than migraine. In addition to stress, disturbed sleep is a common trigger, with chronic tension-type headache often linked to sleep apnea and other sleep disorders (
4,
7). Psychiatric conditions frequently coexist with tension-type headache and insomnia, complicating management. Evidence supports a bidirectional relationship: poor sleep can trigger episodic tension-type headache and promote progression to chronic forms, while many patients with chronic tension-type headache experience insomnia (
3,
4,
7). Cluster headache affects approximately 0.1% of the population, making it rare and challenging to study (
8). Nevertheless, it is considered one of the most severe headache types, highlighting the importance of timely diagnosis and treatment (
5,
8). A genetic association has been reported, with first-degree relatives having an 18-fold increased risk, although the exact inheritance pattern remains unclear and varies between autosomal dominant and autosomal recessive patterns among different families (
6,
8).